Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Net Cash Flow (2016 - 2026)

Integra Lifesciences Holdings' Net Cash Flow history spans 17 years, with the latest figure at $1.3 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 96.82% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$29.3 million, a 24.53% decrease, with the full-year FY2025 number at -$29.3 million, down 24.53% from a year prior.
  • Net Cash Flow hit $1.3 million in Q4 2025 for Integra Lifesciences Holdings, down from $15.1 million in the prior quarter.
  • Over the last five years, Net Cash Flow for IART hit a ceiling of $320.5 million in Q1 2024 and a floor of -$375.5 million in Q2 2024.
  • Historically, Net Cash Flow has averaged -$11.5 million across 5 years, with a median of -$6.6 million in 2023.
  • The widest YoY moves for Net Cash Flow: up 832.74% in 2024, down 18527.13% in 2024.
  • Tracing IART's Net Cash Flow over 5 years: stood at $42.3 million in 2021, then plummeted by 258.78% to -$67.2 million in 2022, then soared by 92.01% to -$5.4 million in 2023, then soared by 832.74% to $39.3 million in 2024, then tumbled by 96.82% to $1.3 million in 2025.
  • Business Quant data shows Net Cash Flow for IART at $1.3 million in Q4 2025, $15.1 million in Q3 2025, and -$33.9 million in Q2 2025.